I'm Out of Here! Twitter is Better. Follow Me There.

Some of you may have noticed recently that we’ve been on well… a bit of a break… and I thought it high time to let you know what’s up with CNTO411, I mean Pharma BlogoSphere.

The long and the short of it is that I don't have the time to write long posts to this blog about other pharma-related blogs and bloggers.

I've decided that Twitter is Better!

It only requires 140 characters! It helps me condense my thoughts and comments into "blog bites" instead of blog posts.

So follow me on Twitter (@pharmaguy).


Follow me on Twitter

Benefits include:

• FREE reprint offers
  
• Instant pharma news updates
  
• Links to interesting people and ideas
  
• More...
  

Dozens of Pharma Blogosphere Bloggers Call It Quits: Cite Economy

"Following Pharmalot's closure and Scott Hensley's departure from the WSJ Health Blog, Insider has decided to throw in the towel." -- Jack Friday at PharmaGossip

"I have to focus on making a living and writing a blog just isn't enough," said Steve Woodruff after he shut down his Impactiviti blog.

The list goes on.

Only two bloggers remain:

• John Mack - Pharma Marketing Blog
• Peter Pitts - Drug Wonks Blog

"I never made any money any way," said John Mack. "So why should I change now?"

"I'm quite well off and enjoy a great government-run health plan," said Peter Pitts. "I also get paid to blog by the pharmaceutical industry."

Although the bloggers who shut down cited monetary problems, an un-named informant from PhRMA told this reporter that PhRMA, the US drug industry trade group, invited at least a dozen pharma bloggers to a symposium at a resort location -- all expenses paid. At press time, this was unconfirmed and PhRMA refused to comment when we did not call them.

Could an all-expense paid educational retreat be the reason why all these bloggers called it quits?

"All PhRMA offered me," said John Mack, "was a bus tour of America in its orange bus. I wasn't about to be holed up in a smelly bus with Montel Williams for days and days! Maybe if they invited me on that retreat I would have reconsidered."

Scott Hensley Quits! What's in Store for WSJ Health Blog?

I noticed that lately the Wall Street Journal Health Blog was a bit light on number of posts being made. At first I thought that not having Ed Silverman and Pharmalot to compete against, the folks at WSJ Health Blog were just being lazy. But now I learn that Scott Hensley is leaving. Here's his farewell post:

A little more than two years ago, I first clicked the publish button on this blog, nervously putting our debut post on the Web. Now, more than 3,900 posts later, I’ve had the pleasure of hitting that button for the last time.

I’m leaving The Wall Street Journal and the blog today. In case you couldn’t tell, it’s been an absolute ball.

The blog launched with high hopes and unknown prospects in March 2007. Happily, from the start the response to our online experiment was extraordinary.

For me, a print reporter turned founding editor of the blog, the thousands of thoughtful reader comments and the kindness of other bloggers have been especially gratifying.

Now I join the ranks of readers of the blog, which I’m confident will carry on just fine without me. If you’d like to stay in touch, the best bet is Twitter, my other fascination.

You can still follow Scott via Twitter: http://twitter.com/scotthensley

But what's going to happen to WSJ Health Blog? Scott says the WSJ Blog will do just fine without him. Jacob Goldstein, Scott's partner, is still posting to the blog, but like other blogs that have lost its "founding" pioneer -- notably Pharmalot and CNTO411 -- WSJ Health Blog may be headed toward obscurity. One hint: Scott refers to the blog as an "experiment," which doesn't sound like a business plan destined to survive.

Pharma Blogosphere Update

Several blogs in the Pharma Blogosphere are now going dark (see "CNTO411: We'll Meet Again, Don't Know Where, Don't Know When"), which is why I am writing this post.

Around this time a few months ago, John Mack introduced the blog Pharma Blogosphere to offer perspective about blogging about the pharmaceutical industry. Though we were initially pretty good at posting content, some of you may have noticed recently that we’ve been on well.. a bit of a break.. and I thought it high time to let you know what’s up with Pharma Blogosphere.

You see, during the past few months, there have been some structural changes to our organization, which have resulted in the consolidation of John Mack and Pharma Marketing News and we are now John Mack Pharma Marketing News. This is an exciting time for us as the spirit and culture of our new organization take shape. That said, we feel it is extremely important that our focus remain on fully integrating our businesses so that we can continue our focus of helping bloggers blog about the pharma industry. What’s more, we have several important milestones that we are preparing for this year related to our core areas of focus pharma marketing, pharma marketing, and pharma marketing.

With all of that activity, we haven’t been very good at posting to Pharma Blogosphere — and I’m afraid this hiatus will continue for the foreseeable future.

In looking back over the past year, admittedly, there were times when we may have missed the mark with Pharma Blogosphere, which some readers promptly brought to our attention. Yet, through this endeavor, we tried to stay true to the intent of blogging through diverse posts including conversations with key bloggers, company announcements, new programs and trends within the industry. There have surely been some challenges along the way, but we have collected some great learnings and, hopefully, visitors have been enriched in some way as well.

In our inaugural post I COULD have said that "we like to think of ourselves as pioneers." We still do as pioneering new blog posts is engrained in the fabric of our culture. And we will continue to provide bloggers with innovative information, the latest information, support services and quality information.

We're taking a break but not exiting indefinitely, so we hope to have the opportunity to chat with you again the near future.